Provided by Tiger Fintech (Singapore) Pte. Ltd.

Akero Therapeutics

53.60
+1.843.55%
Post-market: 53.600.00000.00%19:32 EDT
Volume:1.48M
Turnover:78.72M
Market Cap:4.27B
PE:-14.32
High:53.82
Open:52.65
Low:52.36
Close:51.76
Loading ...
Feb 14, 2023

Beneficial Ownership Change

SC 13G - Statement of acquisition of beneficial ownership by individuals
Feb 14, 2023

Beneficial Ownership Change

SC 13G/A [Amend] - Statement of acquisition of beneficial ownership by individuals
Feb 13, 2023

Beneficial Ownership Change

SC 13G/A [Amend] - Statement of acquisition of beneficial ownership by individuals
Feb 06, 2023

Beneficial Ownership Change

SC 13G/A [Amend] - Statement of acquisition of beneficial ownership by individuals
Dec 05, 2022

Beneficial Ownership Change

SC 13G/A [Amend] - Statement of acquisition of beneficial ownership by individuals
Nov 04, 2022

Major Issues Report

8-K - Current report
Nov 04, 2022

Quarterly Report

10-Q - Quarterly report [Sections 13 or 15(d)]
Sep 16, 2022

Beneficial Ownership Change

SC 13G - Statement of acquisition of beneficial ownership by individuals
Sep 16, 2022

Major Issues Report

8-K - Current report
Sep 15, 2022

Beneficial Ownership Change

SC 13D/A [Amend] - General statement of acquisition of beneficial ownership
Sep 13, 2022

Major Issues Report

8-K - Current report
Aug 05, 2022

Quarterly Report

10-Q - Quarterly report [Sections 13 or 15(d)]
Aug 04, 2022

Major Issues Report

8-K - Current report
Jun 28, 2022

Beneficial Ownership Change

SC 13G - Statement of acquisition of beneficial ownership by individuals
Jun 16, 2022

Major Issues Report

8-K - Current report
Jun 08, 2022

Major Issues Report

8-K - Current report
Jun 03, 2022

Major Issues Report

8-K - Current report
May 06, 2022

Quarterly Report

10-Q - Quarterly report [Sections 13 or 15(d)]
May 06, 2022

Major Issues Report

8-K - Current report
Mar 02, 2022

[Rev.]Annual Report

10-K/A [Amend] - Annual report [Section 13 and 15(d), not S-K Item 405]